Apex Biotechnology Corp. (TPE:1733)
Taiwan · Delayed Price · Currency is TWD 29.30
+0.05 (0.17%)
Jun 18, 2026, 1:30 PM CST
Apex Biotechnology Market Cap
Apex Biotechnology has a market cap or net worth of 2.93 billion as of June 18, 2026. Its market cap has decreased by -6.98% in one year.
Market Cap
2.93B
Enterprise Value
2.37B
Revenue
1.91B
Ranking
n/a
PE Ratio
16.19
Stock Price
29.30
Market Cap Chart
Since September 7, 2001, Apex Biotechnology's market cap has increased from 1.43B to 2.93B, an increase of 105.51%. That is a compound annual growth rate of 2.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.93B | -3.78% |
| Dec 31, 2025 | 3.04B | 1.16% |
| Dec 31, 2024 | 3.01B | -25.31% |
| Dec 29, 2023 | 4.03B | 57.73% |
| Dec 30, 2022 | 2.55B | -1.73% |
| Dec 30, 2021 | 2.60B | 10.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SYN-TECH Chem. & Pharm. | 3.23B |
| Energenesis Biomedical CO.,LTD. | 3.22B |
| Shine-On BioMedical | 3.15B |
| BioGend Therapeutics | 3.10B |
| BRIM Biotechnology | 2.98B |
| Genovate Biotechnology | 2.92B |
| GlycoNex Incorporation | 2.85B |
| Intech Biopharm | 2.74B |